Regulation of Raf-1 by Direct Feedback Phosphorylation
Overview
Authors
Affiliations
The Raf-1 kinase is an important signaling molecule, functioning in the Ras pathway to transmit mitogenic, differentiative, and oncogenic signals to the downstream kinases MEK and ERK. Because of its integral role in cell signaling, Raf-1 activity must be precisely controlled. Previous studies have shown that phosphorylation is required for Raf-1 activation, and here, we identify six phosphorylation sites that contribute to the downregulation of Raf-1 after mitogen stimulation. Five of the identified sites are proline-directed targets of activated ERK, and phosphorylation of all six sites requires MEK signaling, indicating a negative feedback mechanism. Hyperphosphorylation of these six sites inhibits the Ras/Raf-1 interaction and desensitizes Raf-1 to additional stimuli. The hyperphosphorylated/desensitized Raf-1 is subsequently dephosphorylated and returned to a signaling-competent state through interactions with the protein phosphatase PP2A and the prolyl isomerase Pin1. These findings elucidate a critical Raf-1 regulatory mechanism that contributes to the sensitive, temporal modulation of Ras signaling.
Dynamic Coupling of MAPK Signaling to the Guanine Nucleotide Exchange Factor GEF-H1.
Leguay K, Kent O Onco Targets Ther. 2025; 18:147-159.
PMID: 39882405 PMC: 11776410. DOI: 10.2147/OTT.S496228.
An integrative analysis reveals cancer risk associated with artificial sweeteners.
Xie J, Zhu Y, Yang Z, Yu Z, Yang M, Wang Q J Transl Med. 2025; 23(1):32.
PMID: 39780215 PMC: 11708064. DOI: 10.1186/s12967-024-06047-0.
Tsai Y, Fang M, Chen C, Yu I, Shun C, Tao M Commun Biol. 2024; 7(1):1672.
PMID: 39702454 PMC: 11659619. DOI: 10.1038/s42003-024-07357-1.
Quantitative modeling of signaling in aggressive B cell lymphoma unveils conserved core network.
Klinger B, Rausch I, Sieber A, Kutz H, Kruse V, Kirchner M PLoS Comput Biol. 2024; 20(10):e1012488.
PMID: 39352924 PMC: 11469524. DOI: 10.1371/journal.pcbi.1012488.
Miranda-Roman M, Lee C, Fishinevich E, Ran L, Patel A, Yan J Clin Cancer Res. 2024; 30(22):5154-5165.
PMID: 39269317 PMC: 11565172. DOI: 10.1158/1078-0432.CCR-24-1750.